The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study
Open Access
- 22 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Internal and Emergency Medicine
- Vol. 16 (4), 997-1003
- https://doi.org/10.1007/s11739-021-02656-5
Abstract
Background Whether the carriership of inherited antithrombin (AT), protein C (PC), and protein S (PS) deficiency increases the risk of arterial thromboembolic events (ATE) is controversial. This information has the potential to inform the management of family members of probands with inherited deficiency of natural anticoagulants. Patients/methods We conducted a large prospective family cohort study in 640 subjects (of whom 341 carriers and 299 non-carriers) belonging to 86 families with inherited deficiency of AT, PC, or PS. Results A total of 4240 and 3810 patient-years were available for carriers and non-carriers, respectively. Risk factors for atherosclerosis were similarly distributed in the two groups. Of the 26 ATE that were recorded, 19 occurred in carriers (5.6%), as compared to 7 in non-carriers (2.3%) [p = 0.07]. After adjusting for confounders, the hazard ratio (HR) for ATE was 4.9 (95% CI 1.5–16.3) in carriers as compared to non-carriers. Conclusions Among family members of probands with an inherited deficiency of natural anticoagulants, carriers exhibit a risk of ATE that is almost five times higher than in non-carriers.Funding Information
- Università degli Studi di Padova
This publication has 22 references indexed in Scilit:
- Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiencyHaematologica, 2010
- Arterial Thrombosis and the Role of ThrombophiliaSeminars in Thrombosis and Hemostasis, 2007
- The cytoprotective protein C pathwayBlood, 2006
- Risk of arterial thrombosis in carriers of familial thrombophiliaJournal of Thrombosis and Haemostasis, 2006
- Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activitiesFrontiers in Bioscience-Landmark, 2006
- High prevalence of thrombophilia among young patients with myocardial infarction and few conventional risk factorsInternational Journal of Cardiology, 2005
- Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S–C4b binding protein complexBlood, 2004
- Myocardial infarction under the age of 36: prevalence of thrombophilic disordersThrombosis and Haemostasis, 2003
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003
- Laboratory Diagnosis of Hereditary ThrombophiliaSeminars in Thrombosis and Hemostasis, 1998